Differential expression of PD-L1 is observed in multiple classifier endometrial cancer cases, characterised by the presence of two or more mutational patterns, including POLE mutations, dMMR/MSI-H, and p53 abnormalities [42]. This evidence concerns the gene TP53 and endometrial cancer.